20-51790623-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_020436.5(SALL4):c.1860A>G(p.Thr620Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.35 in 1,613,806 control chromosomes in the GnomAD database, including 101,222 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.32 ( 8331 hom., cov: 32)
Exomes 𝑓: 0.35 ( 92891 hom. )
Consequence
SALL4
NM_020436.5 synonymous
NM_020436.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.84
Publications
24 publications found
Genes affected
SALL4 (HGNC:15924): (spalt like transcription factor 4) This gene encodes a zinc finger transcription factor thought to play a role in the development of abducens motor neurons. Defects in this gene are a cause of Duane-radial ray syndrome (DRRS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
SALL4 Gene-Disease associations (from GenCC):
- Duane-radial ray syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
- Duane retraction syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- IVIC syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 20-51790623-T-C is Benign according to our data. Variant chr20-51790623-T-C is described in ClinVar as Benign. ClinVar VariationId is 261260.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.84 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.569 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SALL4 | NM_020436.5 | c.1860A>G | p.Thr620Thr | synonymous_variant | Exon 2 of 4 | ENST00000217086.9 | NP_065169.1 | |
| SALL4 | XM_047440318.1 | c.1554A>G | p.Thr518Thr | synonymous_variant | Exon 2 of 4 | XP_047296274.1 | ||
| SALL4 | NM_001318031.2 | c.1150+710A>G | intron_variant | Intron 2 of 3 | NP_001304960.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SALL4 | ENST00000217086.9 | c.1860A>G | p.Thr620Thr | synonymous_variant | Exon 2 of 4 | 1 | NM_020436.5 | ENSP00000217086.4 | ||
| SALL4 | ENST00000395997.3 | c.1150+710A>G | intron_variant | Intron 2 of 3 | 1 | ENSP00000379319.3 | ||||
| SALL4 | ENST00000371539.7 | c.131-1482A>G | intron_variant | Intron 1 of 2 | 1 | ENSP00000360594.3 |
Frequencies
GnomAD3 genomes AF: 0.322 AC: 48852AN: 151872Hom.: 8341 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
48852
AN:
151872
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.357 AC: 89799AN: 251362 AF XY: 0.364 show subpopulations
GnomAD2 exomes
AF:
AC:
89799
AN:
251362
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.353 AC: 515945AN: 1461818Hom.: 92891 Cov.: 75 AF XY: 0.355 AC XY: 258514AN XY: 727208 show subpopulations
GnomAD4 exome
AF:
AC:
515945
AN:
1461818
Hom.:
Cov.:
75
AF XY:
AC XY:
258514
AN XY:
727208
show subpopulations
African (AFR)
AF:
AC:
6933
AN:
33480
American (AMR)
AF:
AC:
13244
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
10804
AN:
26136
East Asian (EAS)
AF:
AC:
21693
AN:
39700
South Asian (SAS)
AF:
AC:
35208
AN:
86258
European-Finnish (FIN)
AF:
AC:
17137
AN:
53398
Middle Eastern (MID)
AF:
AC:
1976
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
387049
AN:
1111962
Other (OTH)
AF:
AC:
21901
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
24760
49521
74281
99042
123802
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
12610
25220
37830
50440
63050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.321 AC: 48852AN: 151988Hom.: 8331 Cov.: 32 AF XY: 0.324 AC XY: 24086AN XY: 74294 show subpopulations
GnomAD4 genome
AF:
AC:
48852
AN:
151988
Hom.:
Cov.:
32
AF XY:
AC XY:
24086
AN XY:
74294
show subpopulations
African (AFR)
AF:
AC:
8990
AN:
41476
American (AMR)
AF:
AC:
5339
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
1473
AN:
3466
East Asian (EAS)
AF:
AC:
3019
AN:
5144
South Asian (SAS)
AF:
AC:
2087
AN:
4816
European-Finnish (FIN)
AF:
AC:
3344
AN:
10550
Middle Eastern (MID)
AF:
AC:
106
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23390
AN:
67966
Other (OTH)
AF:
AC:
788
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1660
3320
4981
6641
8301
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
498
996
1494
1992
2490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1772
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:5
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
Apr 08, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Duane-radial ray syndrome Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Oculootoradial syndrome Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.